SINT vs. MHUA, MBOT, PAVM, SSKN, NXGL, GCTK, PSTV, PETV, BTCY, and NURO
Should you be buying Sintx Technologies stock or one of its competitors? The main competitors of Sintx Technologies include Meihua International Medical Technologies (MHUA), Microbot Medical (MBOT), PAVmed (PAVM), STRATA Skin Sciences (SSKN), NEXGEL (NXGL), GlucoTrack (GCTK), Plus Therapeutics (PSTV), PetVivo (PETV), Biotricity (BTCY), and NeuroMetrix (NURO). These companies are all part of the "surgical & medical instruments" industry.
Sintx Technologies (NASDAQ:SINT) and Meihua International Medical Technologies (NASDAQ:MHUA) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, analyst recommendations, dividends, media sentiment, risk, institutional ownership, profitability, valuation and earnings.
Meihua International Medical Technologies has higher revenue and earnings than Sintx Technologies.
Sintx Technologies has a beta of 1.39, suggesting that its stock price is 39% more volatile than the S&P 500. Comparatively, Meihua International Medical Technologies has a beta of 0.4, suggesting that its stock price is 60% less volatile than the S&P 500.
In the previous week, Sintx Technologies had 5 more articles in the media than Meihua International Medical Technologies. MarketBeat recorded 7 mentions for Sintx Technologies and 2 mentions for Meihua International Medical Technologies. Meihua International Medical Technologies' average media sentiment score of 1.59 beat Sintx Technologies' score of 1.01 indicating that Meihua International Medical Technologies is being referred to more favorably in the news media.
Meihua International Medical Technologies has a net margin of 0.00% compared to Sintx Technologies' net margin of -318.99%. Meihua International Medical Technologies' return on equity of 0.00% beat Sintx Technologies' return on equity.
Sintx Technologies received 36 more outperform votes than Meihua International Medical Technologies when rated by MarketBeat users.
18.4% of Sintx Technologies shares are held by institutional investors. Comparatively, 1.2% of Meihua International Medical Technologies shares are held by institutional investors. 1.0% of Sintx Technologies shares are held by company insiders. Comparatively, 66.6% of Meihua International Medical Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Summary
Meihua International Medical Technologies beats Sintx Technologies on 7 of the 12 factors compared between the two stocks.
Get Sintx Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for SINT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SINT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Sintx Technologies Competitors List
Related Companies and Tools
